Effects of atrial natriuretic peptide on acute and chronic effects of morphine

Alexej V. Azarov, Gyula Szabó, G. Telegdy

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Atrial natriuretic peptide (ANP) is known to participate in different vegetative functions. The aim of the present study was to investigate the influence of ANP on nociception itself, pain sensitivity to morphine, and the development of acute and chronic tolerance to morphine. Morphine withdrawal signs were also evaluated by injecting naloxone. In adult, male NMRI mice, ANP administered SC or ICV did not affect pain sensitivity itself in a heat-radiant tail-flick test. Peptide treatment, however, depressed the acute nociceptive effect of a single dose of morphine (4 mg/kg, SC) after both SC (20-200 ng/animal) and ICV (5, 10, 20, or 200 ng/animal) ANP administration. ANP given SC and ICV attenuated the development of acute morphine tolerance. Acute morphine tolerance was assessed by giving a bolus injection of morphine (60 mg/kg) 24 h before the pain sensitivity to a challenge dose of morphine (4 mg/kg) was measured. ICV treatment with ANP also blocked the development of chronic morphine tolerance, but did not affect the appearance of naloxone-precipitated withdrawal syndromes. ANP seems to act differently on the development of tolerance to and dependence upon morphine.

Original languageEnglish
Pages (from-to)193-197
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume43
Issue number1
DOIs
Publication statusPublished - 1992

Fingerprint

Atrial Natriuretic Factor
Morphine
Naloxone
Pain
Animals
Morphine Dependence
Nociception
Tail
Hot Temperature
Peptides
Injections
Therapeutics

Keywords

  • ANP
  • Dependence
  • Morphine
  • Pain
  • Tail-flick
  • Tolerance

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Effects of atrial natriuretic peptide on acute and chronic effects of morphine. / Azarov, Alexej V.; Szabó, Gyula; Telegdy, G.

In: Pharmacology, Biochemistry and Behavior, Vol. 43, No. 1, 1992, p. 193-197.

Research output: Contribution to journalArticle

@article{dede783e761d4cdbb4f757a33a9e7c1e,
title = "Effects of atrial natriuretic peptide on acute and chronic effects of morphine",
abstract = "Atrial natriuretic peptide (ANP) is known to participate in different vegetative functions. The aim of the present study was to investigate the influence of ANP on nociception itself, pain sensitivity to morphine, and the development of acute and chronic tolerance to morphine. Morphine withdrawal signs were also evaluated by injecting naloxone. In adult, male NMRI mice, ANP administered SC or ICV did not affect pain sensitivity itself in a heat-radiant tail-flick test. Peptide treatment, however, depressed the acute nociceptive effect of a single dose of morphine (4 mg/kg, SC) after both SC (20-200 ng/animal) and ICV (5, 10, 20, or 200 ng/animal) ANP administration. ANP given SC and ICV attenuated the development of acute morphine tolerance. Acute morphine tolerance was assessed by giving a bolus injection of morphine (60 mg/kg) 24 h before the pain sensitivity to a challenge dose of morphine (4 mg/kg) was measured. ICV treatment with ANP also blocked the development of chronic morphine tolerance, but did not affect the appearance of naloxone-precipitated withdrawal syndromes. ANP seems to act differently on the development of tolerance to and dependence upon morphine.",
keywords = "ANP, Dependence, Morphine, Pain, Tail-flick, Tolerance",
author = "Azarov, {Alexej V.} and Gyula Szab{\'o} and G. Telegdy",
year = "1992",
doi = "10.1016/0091-3057(92)90657-2",
language = "English",
volume = "43",
pages = "193--197",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of atrial natriuretic peptide on acute and chronic effects of morphine

AU - Azarov, Alexej V.

AU - Szabó, Gyula

AU - Telegdy, G.

PY - 1992

Y1 - 1992

N2 - Atrial natriuretic peptide (ANP) is known to participate in different vegetative functions. The aim of the present study was to investigate the influence of ANP on nociception itself, pain sensitivity to morphine, and the development of acute and chronic tolerance to morphine. Morphine withdrawal signs were also evaluated by injecting naloxone. In adult, male NMRI mice, ANP administered SC or ICV did not affect pain sensitivity itself in a heat-radiant tail-flick test. Peptide treatment, however, depressed the acute nociceptive effect of a single dose of morphine (4 mg/kg, SC) after both SC (20-200 ng/animal) and ICV (5, 10, 20, or 200 ng/animal) ANP administration. ANP given SC and ICV attenuated the development of acute morphine tolerance. Acute morphine tolerance was assessed by giving a bolus injection of morphine (60 mg/kg) 24 h before the pain sensitivity to a challenge dose of morphine (4 mg/kg) was measured. ICV treatment with ANP also blocked the development of chronic morphine tolerance, but did not affect the appearance of naloxone-precipitated withdrawal syndromes. ANP seems to act differently on the development of tolerance to and dependence upon morphine.

AB - Atrial natriuretic peptide (ANP) is known to participate in different vegetative functions. The aim of the present study was to investigate the influence of ANP on nociception itself, pain sensitivity to morphine, and the development of acute and chronic tolerance to morphine. Morphine withdrawal signs were also evaluated by injecting naloxone. In adult, male NMRI mice, ANP administered SC or ICV did not affect pain sensitivity itself in a heat-radiant tail-flick test. Peptide treatment, however, depressed the acute nociceptive effect of a single dose of morphine (4 mg/kg, SC) after both SC (20-200 ng/animal) and ICV (5, 10, 20, or 200 ng/animal) ANP administration. ANP given SC and ICV attenuated the development of acute morphine tolerance. Acute morphine tolerance was assessed by giving a bolus injection of morphine (60 mg/kg) 24 h before the pain sensitivity to a challenge dose of morphine (4 mg/kg) was measured. ICV treatment with ANP also blocked the development of chronic morphine tolerance, but did not affect the appearance of naloxone-precipitated withdrawal syndromes. ANP seems to act differently on the development of tolerance to and dependence upon morphine.

KW - ANP

KW - Dependence

KW - Morphine

KW - Pain

KW - Tail-flick

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0026611492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026611492&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(92)90657-2

DO - 10.1016/0091-3057(92)90657-2

M3 - Article

C2 - 1409804

AN - SCOPUS:0026611492

VL - 43

SP - 193

EP - 197

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 1

ER -